Opaleye Management’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Opaleye Management’s Portfolio CELGZ Stock Details CELGZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-340,000	Closed	-$547K	–	59
2015 Q3	$547K	Sell	340,000 -116,492	-26%	-$225K	0.27%	45
2015 Q2	$950K	Sell	456,492 -33,508	-7%	-$85.8K	0.38%	40
2015 Q1	$1.46M	Sell	490,000 -85,000	-15%	-$269K	0.68%	34
2014 Q4	$1.81M	Sell	575,000 -85,000	-13%	-$287K	0.92%	31
2014 Q3	$2.24M	Hold	660,000	–	–	1.74%	20
2014 Q2	$1.72M	Hold	660,000	–	–	1.48%	19
2014 Q1	$1.88M	Sell	660,000 -140,000	-18%	-$423K	1.39%	21
2013 Q4	$2.24M	Buy	+800,000	New	+$2.24M	1.76%	16

Other funds holding CELGZ

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

FCG Advisors Chatham, New Jersey $425M AUM 12.09% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Muhlenkamp & Co Wexford, Pennsylvania $380M AUM 43.74% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Opaleye Management's CELGZ Position: Q4 2015 in Review

Opaleye Management sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q4 2015, closing a stake of 340,000 shares — an estimated $547K sold.

Opaleye Management first reported a position in CELGZ in Q4 2013 and held it in 8 quarters. The position peaked at $2.24M in Q4 2013. 24 funds tracked by Wall St. Rank hold CELGZ as of Q4 2015.

Opaleye Management reported no remaining Celgene Corporation Contingent Value Rights position as of Q4 2015 after selling out during the quarter.
Opaleye Management sold 340,000 Celgene Corporation Contingent Value Rights shares in Q4 2015, an estimated $547K.
Opaleye Management first reported a position in Celgene Corporation Contingent Value Rights in Q4 2013 and held it in 8 quarters.
Opaleye Management's Celgene Corporation Contingent Value Rights position peaked at $2.24M in Q4 2013.
24 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q4 2015.

Based on Opaleye Management's 13F filing for Q4 2015, filed 12 Feb 2016.